Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.
- NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_assertion description "[Furthermore, high S-phase kinase-associated protein 2 immunoreactivity was found to be significantly correlated with reduced expression of P27, P21, and cell-cycle checkpoint kinase 2, as well as with increased expression of transcription factors Dp-1, cyclin D2, and cyclin D1 in hepatocellular carcinoma tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.
- NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_assertion evidence source_evidence_literature NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.
- NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_assertion SIO_000772 22204716 NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.
- NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_assertion wasDerivedFrom befree-20140225 NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.
- NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_assertion wasGeneratedBy ECO_0000203 NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP650275.RA73iKiPKDOQ8dHhj0x84SN87EEoCQ1hGXseek4MoS8K8130_provenance.